Commonwealth Biotechnologies

                   
genengnews.com: Genetic Engineering genengnews.com

Commonwealth Biotechnologies Inc. Provides Discussion of First Quarter 2008 Results and Market...

yahoo.com     May 22, 2008   2 related          

SAN DEIGO--(BUSINESS WIRE)--Commonwealth Biotechnologies, Inc. (“CBI”) (NASDAQ Capital Market:CBTE) today provided a management discussion of its first quarter 2008 financial results and a progress update on Venturepharm (Asia), CBI’s joint venture with Venturepharm Laboratories Ltd (“VPL”)...                    

comments

                   

China Biopharma: What’s Not to Like?

seekingalpha.com     May 11, 2008          

ChinaBio Today submits: China-based biopharmas were rolling out their financial reports from Q1 last week, and the results were uniformly positive – revenues and profits were substantially higher than the comparable period a year ago. That good news, however, is not reflected in the price of most...                    

comments

                   
genengnews.com: Genetic Engineering genengnews.com

Commonwealth Biotechnologies to Establish New Drug Discovery Service Facilities in China and...

genengnews.com     May 6, 2008          

News source: Business Wire Commonwealth Biotechnologies, Inc. ("CBI") (NASDAQ Capital Market: CBTE) is pleased to announce further details regarding Venturepharm (Asia), CBI's joint venture with Venturepharm Laboratories Ltd ("VPL") (HKEX: 8225.HK). The joint venture was...                    

comments

CBI and NZP Join Hands for Glycotherapeutic Drug Development

redorbit.com     Apr 16, 2008   2 related          

Commonwealth Biotechnologies has entered into a global strategic alliance with New Zealand Pharmaceuticals to provide a suite of small molecule chemistry products for the drug discovery and development market. ... The alliance will focus on providing glycotherapeutic...                    

comments

Market Update: Commonwealth Biotechnologies Reports New Drug Discovery Contract Signings and...

yahoo.com     Apr 8, 2008   3 related          

RICHMOND, Va.----Commonwealth Biotechnologies, Inc. is pleased to announce new signings and growth initiatives for its business units including Exelgen Ltd , CBI Services, Mimotopes Pty Ltd , and Fairfax Identity Laboratories . ... RICHMOND, Va.--(BUSINESS...                    

comments

Downturn in China Biotech Stocks Shows No Impact on Activity (at Seeking Alpha)

yahoo.com     Apr 7, 2008   1 related          

by: ChinaBio Today posted on: April 07, 2008 | about stocks: With the first quarter of 2008 officially history, the news for US-listed China biomedical companies was not good: a loss of 27% in the ChinaBio Index (see story). But the downturn in stock prices hasn’t seemed...                    

comments

Commonwealth Forms Joint Venture with Venturepharm for Outsourcing Services

seekingalpha.com     Apr 4, 2008   3 related          

ChinaBio Today submits: Commonwealth Biotechnologies, Inc. (CBTE) and Venturepharm Laboratories Ltd [HKEX: 8225] have formed a China-based joint venture that will provide a continuous spectrum of outsourcing services.Complete Story » ... posted on: April 04, 2008 | about...                    

comments

OTCPicks.com: OTCPicks.com Stocks to Watch for Thursday, April 3rd CTAL, POWN, MIHS, NHNV, EESO,...

tmcnet.com     Apr 3, 2008          

OTCPicks.com: OTCPicks.com Stocks to Watch for Thursday, April 3rd CTAL, POWN, MIHS, NHNV, EESO, CBTE ... (M2 PressWIRE Via Thomson Dialog NewsEdge) Our Stocks to Watch tomorrow include Centale Inc. (OTCBB: CTAL), POW Entertainment Inc. (OTC: POWN), Medical Institutional...                    

comments

Commonwealth Signs 2 Contracts

chron.com     Apr 2, 2008   1 related          

RICHMOND, Va. — Commonwealth Biotechnologies Inc. unit Exelgen said Wednesday it signed two drug discovery contracts with major pharmaceutical companies. ... The company did not disclose the names of the companies, though it said one is U.S.-based and one is based in...                    

comments

Exelgen, Ltd, a Subsidiary of Commonwealth Biotechnologies, Inc., Announces Two New Major Drug...

yahoo.com     Apr 2, 2008   2 related          

RICHMOND, Va. & BUDE, England----Exelgen, Ltd, a wholly owned subsidiary of Commonwealth Biotechnologies, Inc. and a leading provider of drug discovery chemistry services and small molecule products, announced today that it has entered into two new drug discovery collaborations: one with a...                    

comments